Evidence map›Paper›PMID 39544741›Full record

ArticleAmerican journal of translational research2024

A rare metachronous primary clear cell renal cell carcinoma and pancreatic ductal adenocarcinoma: case report and literature review.

Ye-Li Zhu, Chun-Hui Zhou, Fan-Chuang Kong, Xiao-Lin Liu, Xiao-Guang Wang, Jing Chen, Yan-Hua Huang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ye-Li ZhuDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.
Chun-Hui ZhouDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.
Fan-Chuang KongDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.
Xiao-Lin LiuDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.
Xiao-Guang WangDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.
Jing ChenDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.
Yan-Hua HuangDepartment of General Surgery, The Second Affiliated Hospital of Jiaxing University Jiaxing 314000, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetastatic spread to the pancreas from renal cell carcinoma is a relatively rare event. Even rarer is the metachronous occurrence of clear cell renal cell carcinoma (ccRCC) and pancreatic ductal adenocarcinoma (PDAC). Our case report contributes to the existing literature by documenting the unusual occurrence of metachronous ccRCC and PDAC in a 69-year-old patient, and we review the literature.

Indexed as

case reportclear cell renal cell carcinomaMetachronous primary carcinomapancreatic ductal adenocarcinoma

Identifiers

PMID39544741
PMCPMC11558432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.